Discover
GMED
Globus Medical, Inc.
75.96
500 x 74.98
600 x 77.00
bid
ask
-
3.05
3.86%
550 @ 07:20 AM
77.00 +1.04 (1.37%)
| Ytd | -13.00% | |
| 1y | 26.18% |
75.14
day range
80.21
51.79
52 week range
101.40
| Open | 79.47 | Prev Close | 79.01 | Low | 75.14 | High | 80.21 | Mkt Cap | 10.31B |
| Vol | 2.66M | Avg Vol | 1.66M | EPS | 4.28 | P/E | 17.75 | Forward P/E | 14.76 |
| Beta | 0.95 | Short Ratio | 3.09 | Inst. Own | 101.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 83.01 | 200-d Avg | 81.78 | 1yr Est | 108.64 |
| Income Statement | |||
| Total Revenue | 759.85M | ||
| Revenues (USD) | 759.85M | ||
| Cost of Revenue | 234.07M | ||
| Gross Profit | 525.79M | ||
| Operating Expenses | 375.40M | ||
| Research and Development Expense | 36.51M | ||
| Selling, General and Administrative Expense | 297.77M | ||
| Operating Income | 150.39M | ||
| Interest Expense | -5.43M | ||
| Income Tax Expense | 32.77M | ||
| Net Income | 124.30M | ||
| Net Income Common Stock | 124.30M | ||
| Net Income Common Stock (USD) | 124.30M | ||
| Consolidated Income | 124.30M | ||
| Earnings per Basic Share | 0.92 | ||
| Earnings per Basic Share (USD) | 0.92 | ||
| Earnings per Diluted Share | 0.90 | ||
| Earning Before Interest & Taxes (EBIT) | 151.64M | ||
| Earning Before Interest & Taxes (USD) | 151.64M | ||
| Weighted Average Shares | 135.36M | ||
| Weighted Average Shares Diluted | 138.19M | ||
| Balance Sheet | |||
| Cash and Equivalents | 560.95M | ||
| Cash and Equivalents (USD) | 560.95M | ||
| Investments | 238.34M | ||
| Investments Current | 68.90M | ||
| Investments Non-Current | 169.44M | ||
| Trade and Non-Trade Receivables | 686.43M | ||
| Current Assets | 2.20B | ||
| Property, Plant & Equipment Net | 618.65M | ||
| Total Assets | 5.44B | ||
| Debt Current | 15.12M | ||
| Total Debt | 115.22M | ||
| Current Liabilities | 482.46M | ||
| Debt Non-Current | 100.10M | ||
| Total Liabilities | 707.24M | ||
| Accumulated Retained Earnings (Deficit) | 1.51B | ||
| Accumulated Other Comprehensive Income | 14.40M | ||
| Shareholders Equity | 4.73B | ||
| Shareholders Equity (USD) | 4.73B | ||
| Assets Non-Current | 3.24B | ||
| Total Debt (USD) | 115.22M | ||
| Deferred Revenue | 26.35M | ||
| Goodwill and Intangible Assets | 2.16B | ||
| Inventory | 772.60M | ||
| Liabilities Non-Current | 224.78M | ||
| Trade and Non-Trade Payables | 103.66M | ||
| Tax Assets | 263.82M | ||
| Tax Liabilities | 27.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 69.86M | ||
| Net Cash Flow from Financing | 18.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 34.79M | ||
| Capital Expenditure | -39.61M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -4.91M | ||
| Issuance (Purchase) of Equity Shares | 25.96M | ||
| Net Cash Flow from Investing | -182.67M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -138.15M | ||
| Net Cash Flow from Operations | 202.36M | ||
| Effect of Exchange Rate Changes on Cash | -3.09M | ||
| Share Based Compensation | 12.62M | ||